Why the study?
Does carnosic acid prevent cyclophosphamide-induced cardiotoxicity in male Wistar rats?
Population
40 male Wistar rats
Comparison
Carnosic acid 100 mg/kg orally for 14 days, with… vs Cyclophosphamide alone, CA alone, and untreated…
Design
Preclinical
Follow-up
14 days
Key result
Carnosic acid (100 mg/kg) attenuated cyclophosphamide-induced cardiotoxicity in rats through antioxidant, anti-inflammatory, and anti-apoptotic properties.
Authors
Loading...
Cautions against clinical use; leaves open translation of rat cardioprotection to human cyclophosphamide therapy.
Does carnosic acid prevent cyclophosphamide-induced cardiotoxicity in male Wistar rats?
Carnosic acid shows therapeutic potential as a natural cardioprotective agent against chemotherapy-associated cardiac injury in a rat model.
Salah et al. (2026) studied Cyclophosphamide-induced cardiotoxicity (n=40). Carnosic acid vs. Cyclophosphamide alone was evaluated on Cardiac injury assessed via serum biomarkers, histology, and oxidative stress markers. Carnosic acid (100 mg/kg) attenuated cyclophosphamide-induced cardiotoxicity in rats through antioxidant, anti-inflammatory, and anti-apoptotic properties.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: